|

Romidepsin Clinical Trials

2 actively recruiting trials across 2 locations

Also known as: Depsipeptide

Pipeline

Phase 1: 1Phase 1/2: 1

Top Sponsors

  • University of Virginia1
  • H. Lee Moffitt Cancer Center and Research Institute1

Indications

  • Cancer2
  • Bladder Cancer1
  • Lymphoma, T-Cell1

Tampa, Florida1 trial

Study Investigating Intravesical HDAC Inhibition to Improve Response to Immuno-Oncology Agents

Moffitt Cancer Center

Phase 1

Charlottesville, Virginia1 trial

Durvalumab in Different Combinations With Pralatrexate, Romidepsin and Oral 5-Azacitidine for Lymphoma

University of Virginia

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.